Source: Annual Congress 2002 - New strategies in lung transplantation
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. M. Rutherford, J. H. Dark, K. Gould, P. A. Corris (Newcastle upon Tyne, United Kingdom). Taurolidine in the management of lung transplant recipients with cystic fibrosis colonized with burkholderia cepacia. Eur Respir J 2002; 20: Suppl. 38, 3501

Member's Comments

No comment yet.

Related content which might interest you: Survival outcomes following lung transplantation for cystic fibrosis patients infected with Burkholderia cenocepacia Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007 Treatment of Burholderia cepacia infection in patients with cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 539s Year: 2001 Burkholderia cepacia infection in adult cystic fibrosis patients: Its impact on lung function and survival Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Inhaled colistin following lung transplantation in colonised cystic fibrosis patients Source: Eur Respir J 2013; 42: 542-544 Year: 2013 Nebulized heparin in Burkholderia cepacia colonized adult cystic fibrosis patients Source: Eur Respir J 2001; 17: 36-38 Year: 2001 Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients Source: Eur Respir J 2004; 23: 851-856 Year: 2004 Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 379s Year: 2002 Azithromycin in chronic respiratory infections with pseudomonas aeruginosa in patients without cystic fibrosis Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 Burkholderia cepacia complex infection in Czech patients with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 503s Year: 2003 Fatal invasive aspergillosis in a non-neutropenic cystic fibrosis patient post liver transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 402s Year: 2005 Bacterial infection and lung function in patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 615s Year: 2005 Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung Source: Eur Respir J , 49 (4)  1602108; DOI: 10.1183/13993003.02108-2016 Year: 2017 Pulmonary cladophialophora boppii infection in a lung transplant recipient Source: Eur Respir J 2006; 28: Suppl. 50, 777s Year: 2006 Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre Source: Eur Respir J 2006; 27: 937-943 Year: 2006 Difficult issues in the selection of cystic fibrosis patients for lung transplantation Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=139 Year: 2006 Survival and lung function in double lung transplant recipients with cystic fibrosis Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome Year: 2017 Outcomes and survival following lung transplantation in non-cystic fibrosis bronchiectasis Source: ERJ Open Res, 8 (1) 00607-2021; 10.1183/23120541.00607-2021 Year: 2022 Emerging pathogens in cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=66 Year: 2006 Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis Source: ERJ Open Res, 4 (2) 00162-2017; 10.1183/23120541.00162-2017 Year: 2018